Long Noncoding RNAs in Human Cancer and Apoptosis

Brannan, C.I.; Dees, E.C.; Ingram, R.S.; Tilghman, S.M. The product of the H19 gene may function as an RNA. Mol. Cell. Biol., 1990, 10(1), 28-36.
[http://dx.doi.org/10.1128/MCB.10.1.28] [PMID: 1688465]

Jarroux, J.; Morillon, A.; Pinskaya, M. History, Discovery, and Classification of LncRNAs. Advances in Experimental Medicine and Biology. Springer New York LLC; , 2017, 1008, pp. 1-46.
[http://dx.doi.org/10.1007/978-981-10-5203-3_1]

Memczak, S.; Jens, M.; Elefsinioti, A.; Torti, F.; Krueger, J.; Rybak, A.; Maier, L.; Mackowiak, S.D.; Gregersen, L.H.; Munschauer, M.; Loewer, A.; Ziebold, U.; Landthaler, M.; Kocks, C.; le Noble, F.; Rajewsky, N. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature, 2013, 495(7441), 333-338.
[http://dx.doi.org/10.1038/nature11928] [PMID: 23446348]

Bhat, S.A.; Ahmad, S.M.; Mumtaz, P.T.; Malik, A.A.; Dar, M.A.; Urwat, U.; Shah, R.A.; Ganai, N.A. Long non-coding RNAS: Mechanism of action and functional utility. Noncoding RNA Research, 2016, 1(1), 43-50.
[http://dx.doi.org/10.1016/j.ncrna.2016.11.002]

Chen, J.; Sun, M.; Kent, W.J.; Huang, X.; Xie, H.; Wang, W.; Zhou, G.; Shi, R.Z.; Rowley, J.D. Over 20% of human transcripts might form sense-antisense pairs. Nucleic Acids Res., 2004, 32(16), 4812-4820.
[http://dx.doi.org/10.1093/nar/gkh818] [PMID: 15356298]

Han, P.; Li, J.W.; Zhang, B.M.; Lv, J.C.; Li, Y.M.; Gu, X.Y.; Yu, Z.W.; Jia, Y.H.; Bai, X.F.; Li, L.; Liu, Y.L.; Cui, B.B. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling. Mol. Cancer, 2017, 16(1), 9.
[http://dx.doi.org/10.1186/s12943-017-0583-1] [PMID: 28086904]

Luo, Z.F.; Zhao, D.; Li, X.Q.; Cui, Y.X.; Ma, N.; Lu, C.X.; Liu, M.Y.; Zhou, Y. Clinical significance of HOTAIR expression in colon cancer. World J. Gastroenterol., 2016, 22(22), 5254-5259.
[http://dx.doi.org/10.3748/wjg.v22.i22.5254] [PMID: 27298568]

Yeasmin, F.; Yada, T.; Akimitsu, N. Micropeptides encoded in transcripts previously identified as long noncoding RNAs: A new chapter in transcriptomics and proteomics. Front. Genet., 2018, 9, 144.
[http://dx.doi.org/10.3389/fgene.2018.00144] [PMID: 29922328]

Ye, M.; Zhang, J.; Wei, M.; Liu, B.; Dong, K. Emerging role of long noncoding RNA-encoded micropeptides in cancer. Cancer Cell Int., 2020, 20(1), 506.
[http://dx.doi.org/10.1186/s12935-020-01589-x] [PMID: 33088214]

Kapranov, P.; St Laurent, G.; Raz, T.; Ozsolak, F.; Reynolds, C.P.; Sorensen, P.H.B.; Reaman, G.; Milos, P.; Arceci, R.J.; Thompson, J.F.; Triche, T.J. The majority of total nuclear-encoded non-ribosomal RNA in a human cell is ‘dark matter’ un-annotated RNA. BMC Biol., 2010, 8(1), 149.
[http://dx.doi.org/10.1186/1741-7007-8-149] [PMID: 21176148]

Mercer, T.R.; Gerhardt, D.J.; Dinger, M.E.; Crawford, J.; Trapnell, C.; Jeddeloh, J.A.; Mattick, J.S.; Rinn, J.L. Targeted RNA sequencing reveals the deep complexity of the human transcriptome. Nat. Biotechnol., 2011, 30(1), 99-104.
[http://dx.doi.org/10.1038/nbt.2024] [PMID: 22081020]

He, Y.; Vogelstein, B.; Velculescu, V. E.; Papadopoulos, N.; Kinzler, K. W. The antisense transcriptomes of human cells. Science (80-.), 2008, 322(5909), 1855-1857.
[http://dx.doi.org/10.1126/science.1163853]

Faust, T.; Frankel, A.; D’Orso, I. Transcription control by long non-coding RNAs. Transcription, 2012, 3(2), 78-86.
[http://dx.doi.org/10.4161/trns.19349] [PMID: 22414755]

van Bakel, H.; Nislow, C.; Blencowe, B.J.; Hughes, T.R. Most “dark matter” transcripts are associated with known genes. PLoS Biol., 2010, 8(5), e1000371.
[http://dx.doi.org/10.1371/journal.pbio.1000371] [PMID: 20502517]

Ma, L.; Bajic, V.B.; Zhang, Z. On the classification of long non-coding RNAs. RNA Biol., 2013, 10(6), 925-933.
[http://dx.doi.org/10.4161/rna.24604] [PMID: 23696037]

Ulitsky, I.; Bartel, D.P. lincRNAs: Genomics, evolution, and mechanisms. Cell, 2013, 154(1), 26-46.
[http://dx.doi.org/10.1016/j.cell.2013.06.020] [PMID: 23827673]

Dinger, M.E.; Pang, K.C.; Mercer, T.R.; Mattick, J.S. Differentiating protein-coding and noncoding RNA: Challenges and ambiguities. PLOS Comput. Biol., 2008, 4(11), e1000176-e1000176.
[http://dx.doi.org/10.1371/journal.pcbi.1000176] [PMID: 19043537]

Louro, R.; Smirnova, A.S.; Verjovski-Almeida, S. Long intronic noncoding RNA transcription: Expression noise or expression choice? Genomics, 2009, 93(4), 291-298.
[http://dx.doi.org/10.1016/j.ygeno.2008.11.009] [PMID: 19071207]

Chen, L-L. Linking Long Noncoding RNA Localization and Function. Trends Biochem. Sci., 2016, 41(9), 761-772.
[http://dx.doi.org/10.1016/j.tibs.2016.07.003] [PMID: 27499234]

Volders, P-J.; Anckaert, J.; Verheggen, K.; Nuytens, J.; Martens, L.; Mestdagh, P.; Vandesompele, J. LNCipedia 5: Towards a reference set of human long non-coding RNAs. Nucleic Acids Res., 2019, 47(D1), D135-D139.
[http://dx.doi.org/10.1093/nar/gky1031] [PMID: 30371849]

Ponting, C.P.; Oliver, P.L.; Reik, W. Evolution and functions of long noncoding RNAs. Cell, 2009, 136(4), 629-641.
[http://dx.doi.org/10.1016/j.cell.2009.02.006] [PMID: 19239885]

Hangauer, M.J.; Vaughn, I.W.; McManus, M.T. Pervasive transcription of the human genome produces thousands of previously unidentified long intergenic noncoding RNAs. PLoS Genet., 2013, 9(6), e1003569-e1003569.
[http://dx.doi.org/10.1371/journal.pgen.1003569] [PMID: 23818866]

Kopp, F.; Mendell, J.T. Functional classification and experimental dissection of long noncoding RNAs. Cell, 2018, 393-407.
[http://dx.doi.org/10.1016/j.cell.2018.01.011]

Schmitz, S.U.; Grote, P.; Herrmann, B.G. Mechanisms of long noncoding rna function in development and disease. Cell. Mol. Life Sci., 2016, 2491-2509.
[http://dx.doi.org/10.1007/s00018-016-2174-5]

Wang, K.C.; Chang, H.Y. Molecular mechanisms of long noncoding RNAs. Mol. Cell, 2011, 43(6), 904-914.
[http://dx.doi.org/10.1016/j.molcel.2011.08.018] [PMID: 21925379]

Tripathi, V.; Ellis, J.D.; Shen, Z.; Song, D.Y.; Pan, Q.; Watt, A.T.; Freier, S.M.; Bennett, C.F.; Sharma, A.; Bubulya, P.A.; Blencowe, B.J.; Prasanth, S.G.; Prasanth, K.V. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol. Cell, 2010, 39(6), 925-938.
[http://dx.doi.org/10.1016/j.molcel.2010.08.011] [PMID: 20797886]

Alkan, A.H.; Akgül, B. Endogenous miRNA Sponges. Methods Mol. Biol., 2022, 2257, 91-104.
[http://dx.doi.org/10.1007/978-1-0716-1170-8_5] [PMID: 34432275]

Wutz, A.; Rasmussen, T.P.; Jaenisch, R. Chromosomal silencing and localization are mediated by different domains of Xist RNA. Nat. Genet., 2002, 30(2), 167-174.
[http://dx.doi.org/10.1038/ng820] [PMID: 11780141]

Tsai, M.C.; Manor, O.; Wan, Y.; Mosammaparast, N.; Wang, J.K.; Lan, F.; Shi, Y.; Segal, E.; Chang, H.Y. Long noncoding RNA as modular scaffold of histone modification complexes. Science, 2010, 329(5992), 689-693.
[http://dx.doi.org/10.1126/science.1192002] [PMID: 20616235]

Sun, M.; Nie, F.; Wang, Y.; Zhang, Z.; Hou, J.; He, D.; Xie, M.; Xu, L.; De, W.; Wang, Z.; Wang, J. LncRNA HOXA11-AS Promotes Proliferation and Invasion of Gastric Cancer by Scaffolding the Chromatin Modification Factors PRC2, LSD1, and DNMT1. Cancer Res., 2016, 76(21), 6299-6310.
[http://dx.doi.org/10.1158/0008-5472.CAN-16-0356] [PMID: 27651312]

Chujo, T.; Yamazaki, T.; Kawaguchi, T.; Kurosaka, S.; Takumi, T.; Nakagawa, S.; Hirose, T. Unusual semi-extractability as a hallmark of nuclear body-associated architectural noncoding RNAs. EMBO J., 2017, 36(10), 1447-1462.
[http://dx.doi.org/10.15252/embj.201695848] [PMID: 28404604]

Clemson, C.M.; Hutchinson, J.N.; Sara, S.A.; Ensminger, A.W.; Fox, A.H.; Chess, A.; Lawrence, J.B. An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles. Mol. Cell, 2009, 33(6), 717-726.
[http://dx.doi.org/10.1016/j.molcel.2009.01.026] [PMID: 19217333]

Staněk, D.; Fox, A. Nuclear bodies: News insights into structure and function. Curr Opin. Cell Bio., 2017, 94-101.
[http://dx.doi.org/10.1016/j.ceb.2017.05.001]

Bunch, H.; Lawney, B.P.; Burkholder, A.; Ma, D.; Zheng, X.; Motola, S.; Fargo, D.C.; Levine, S.S.; Wang, Y.E.; Hu, G. RNA polymerase II promoter-proximal pausing in mammalian long non-coding genes. Genomics, 2016, 108(2), 64-77.
[http://dx.doi.org/10.1016/j.ygeno.2016.07.003] [PMID: 27432546]

Meller, V.H.; Joshi, S.S.; Deshpande, N. Modulation of Chromatin by Noncoding RNA. Annu. Rev. Genet., 2015, 49(1), 673-695.
[http://dx.doi.org/10.1146/annurev-genet-112414-055205] [PMID: 26631517]

Long, Y.; Wang, X.; Youmans, D.T.; Cech, T.R. G E N E E X P R E S S I O N How do lncRNAs regulate transcription? Sci. Adv., 2017, 3(9), eaao2110.

Bryzghalov, O. Szcześniak, M.W.; Makałowska, I. Retroposition as a source of antisense long non-coding RNAs with possible regulatory functions. Acta Biochim. Pol., 2016, 63(4), 825-833.
[http://dx.doi.org/10.18388/abp.2016_1354] [PMID: 27801428]

Hombach, S.; Kretz, M. Non-Coding RNAs: Classification, Biology and Functioning BT - Non-Coding RNAs in Colorectal Cancer; Slaby, O; Calin, G.A., Ed.; Springer International Publishing: Cham, 2016, pp. 3-17.
[http://dx.doi.org/10.1007/978-3-319-42059-2_1]

Galluzzi, L.; Vitale, I.; Aaronson, S.A.; Abrams, J.M.; Adam, D.; Agostinis, P.; Alnemri, E.S.; Altucci, L.; Amelio, I.; Andrews, D.W.; Annicchiarico-Petruzzelli, M.; Antonov, A.V.; Arama, E.; Baehrecke, E.H.; Barlev, N.A.; Bazan, N.G.; Bernassola, F.; Bertrand, M.J.M.; Bianchi, K.; Blagosklonny, M.V.; Blomgren, K.; Borner, C.; Boya, P.; Brenner, C.; Campanella, M.; Candi, E.; Carmona-Gutierrez, D.; Cecconi, F.; Chan, F.K.; Chandel, N.S.; Cheng, E.H.; Chipuk, J.E.; Cidlowski, J.A.; Ciechanover, A.; Cohen, G.M.; Conrad, M.; Cubillos-Ruiz, J.R.; Czabotar, P.E.; D’Angiolella, V.; Dawson, T.M.; Dawson, V.L.; De Laurenzi, V.; De Maria, R.; Debatin, K.M.; DeBerardinis, R.J.; Deshmukh, M.; Di Daniele, N.; Di Virgilio, F.; Dixit, V.M.; Dixon, S.J.; Duckett, C.S.; Dynlacht, B.D.; El-Deiry, W.S.; Elrod, J.W.; Fimia, G.M.; Fulda, S. García-Sáez, A.J.; Garg, A.D.; Garrido, C.; Gavathiotis, E.; Golstein, P.; Gottlieb, E.; Green, D.R.; Greene, L.A.; Gronemeyer, H.; Gross, A.; Hajnoczky, G.; Hardwick, J.M.; Harris, I.S.; Hengartner, M.O.; Hetz, C.; Ichijo, H.; Jäättelä, M.; Joseph, B.; Jost, P.J.; Juin, P.P.; Kaiser, W.J.; Karin, M.; Kaufmann, T.; Kepp, O.; Kimchi, A.; Kitsis, R.N.; Klionsky, D.J.; Knight, R.A.; Kumar, S.; Lee, S.W.; Lemasters, J.J.; Levine, B.; Linkermann, A.; Lipton, S.A.; Lockshin, R.A.; López-Otín, C.; Lowe, S.W.; Luedde, T.; Lugli, E.; MacFarlane, M.; Madeo, F.; Malewicz, M.; Malorni, W.; Manic, G.; Marine, J.C.; Martin, S.J.; Martinou, J.C.; Medema, J.P.; Mehlen, P.; Meier, P.; Melino, S.; Miao, E.A.; Molkentin, J.D.; Moll, U.M.; Muñoz-Pinedo, C.; Nagata, S.; Nuñez, G.; Oberst, A.; Oren, M.; Overholtzer, M.; Pagano, M.; Panaretakis, T.; Pasparakis, M.; Penninger, J.M.; Pereira, D.M.; Pervaiz, S.; Peter, M.E.; Piacentini, M.; Pinton, P.; Prehn, J.H.M.; Puthalakath, H.; Rabinovich, G.A.; Rehm, M.; Rizzuto, R.; Rodrigues, C.M.P.; Rubinsztein, D.C.; Rudel, T.; Ryan, K.M.; Sayan, E.; Scorrano, L.; Shao, F.; Shi, Y.; Silke, J.; Simon, H.U.; Sistigu, A.; Stockwell, B.R.; Strasser, A.; Szabadkai, G.; Tait, S.W.G.; Tang, D.; Tavernarakis, N.; Thorburn, A.; Tsujimoto, Y.; Turk, B.; Vanden Berghe, T.; Vandenabeele, P.; Vander Heiden, M.G.; Villunger, A.; Virgin, H.W.; Vousden, K.H.; Vucic, D.; Wagner, E.F.; Walczak, H.; Wallach, D.; Wang, Y.; Wells, J.A.; Wood, W.; Yuan, J.; Zakeri, Z.; Zhivotovsky, B.; Zitvogel, L.; Melino, G.; Kroemer, G. Molecular mechanisms of cell death: Recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ., 2018, 25(3), 486-541.
[http://dx.doi.org/10.1038/s41418-017-0012-4] [PMID: 29362479]

Chao, M.P.; Majeti, R.; Weissman, I.L. Programmed cell removal: A new obstacle in the road to developing cancer. Nat. Rev. Cancer, 2011, 12(1), 58-67.
[http://dx.doi.org/10.1038/nrc3171] [PMID: 22158022]

Hotchkiss, R.S.; Strasser, A.; McDunn, J.E.; Swanson, P.E. Cell death. N. Engl. J. Med., 2009, 361(16), 1570-1583.
[http://dx.doi.org/10.1056/NEJMra0901217] [PMID: 19828534]

Ouyang, L.; Shi, Z.; Zhao, S.; Wang, F-T.; Zhou, T-T.; Liu, B.; Bao, J-K. Programmed cell death pathways in cancer: A review of apoptosis, autophagy and programmed necrosis. Cell Prolif., 2012, 45(6), 487-498.
[http://dx.doi.org/10.1111/j.1365-2184.2012.00845.x] [PMID: 23030059]

Singh, R.; Letai, A.; Sarosiek, K. Regulation of apoptosis in health and disease: The balancing act of BCL-2 family proteins. Nat. Rev. Mol. Cell Biol., 2019, 20(3), 175-193.
[http://dx.doi.org/10.1038/s41580-018-0089-8] [PMID: 30655609]

Lockshin, R.A.; Williams, C.M. Programmed Cell Death-I. Cytology of Degeneration in the Intersegmental Muscles of the Pernyi Silkmoth. J. Insect Physiol., 1965, 11(2), 123-133.
[http://dx.doi.org/10.1016/0022-1910(65)90099-5] [PMID: 14287218]

Vanden Berghe, T.; Linkermann, A.; Jouan-Lanhouet, S.; Walczak, H.; Vandenabeele, P. Regulated necrosis: The expanding network of non-apoptotic cell death pathways. Nat. Rev. Mol. Cell Biol., 2014, 15(2), 135-147.
[http://dx.doi.org/10.1038/nrm3737] [PMID: 24452471]

Napoletano, F.; Baron, O.; Vandenabeele, P.; Mollereau, B.; Fanto, M. Intersections between Regulated Cell Death and Autophagy. Trends Cell Biol., 2019, 29(4), 323-338.
[http://dx.doi.org/10.1016/j.tcb.2018.12.007] [PMID: 30665736]

Teng, X.; Hardwick, J.M. Cell death in genome evolution. Semin. Cell Dev. Biol., 2015, 39, 3-11.
[http://dx.doi.org/10.1016/j.semcdb.2015.02.014] [PMID: 25725369]

Kerr, J.F.R.; Wyllie, A.H.; Currie, A.R. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer, 1972, 26(4), 239-257.
[http://dx.doi.org/10.1038/bjc.1972.33] [PMID: 4561027]

Blank, M.; Shiloh, Y. Programs for cell death: Apoptosis is only one way to go. Cell Cycle, 2007, 686-695.
[http://dx.doi.org/10.4161/cc.6.6.3990]

Morrill, S.; He, D.Z.Z. Apoptosis in inner ear sensory hair cells. Journal of Otology, 2017, 151-164.
[http://dx.doi.org/10.1016/j.joto.2017.08.001]

Pistritto, G.; Trisciuoglio, D.; Ceci, C.; Garufi, A.; D’Orazi, G. Apoptosis as anticancer mechanism: Function and dysfunction of its modulators and targeted therapeutic strategies. Aging (Albany NY), 2016, 8(4), 603-619.
[http://dx.doi.org/10.18632/aging.100934] [PMID: 27019364]

Ashkenazi, A.; Dixit, V. M. Death receptors: Signaling and modulation. Science (80-. ), 1998, 281(5381), 1305-LP-1308..
[http://dx.doi.org/10.1126/science.281.5381.1305]

Watanabe-Fukunaga, R.; Brannan, C.I.; Copeland, N.G.; Jenkins, N.A.; Nagata, S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature, 1992, 356(6367), 314-317.
[http://dx.doi.org/10.1038/356314a0] [PMID: 1372394]

Vanamee, É.S.; Faustman, D.L. Structural Principles of Tumor Necrosis Factor Superfamily Signaling; , 2018, 11, .

Wang, C.; Youle, R.J. The role of mitochondria in apoptosis. Annu. Rev. Genet., 2009, 43(1), 95-118.
[http://dx.doi.org/10.1146/annurev-genet-102108-134850] [PMID: 19659442]

Kalkavan, H.; Green, D.R. MOMP, cell suicide as a BCL-2 family business. Cell Death Differ., 2018, 25(1), 46-55.
[http://dx.doi.org/10.1038/cdd.2017.179] [PMID: 29053143]

Zhang, M.; Zheng, J.; Nussinov, R.; Ma, B. Release of Cytochrome C from Bax Pores at the Mitochondrial Membrane/631/114/2397/639/638/440/56/119/118 Article. Sci. Rep., 2017, 7(1)
[http://dx.doi.org/10.1038/s41598-017-02825-7] [PMID: 28572603]

Bender, T.; Martinou, J.C. Where killers meet--permeabilization of the outer mitochondrial membrane during apoptosis. Cold Spring Harb. Perspect. Biol., 2013, 5(1), a011106.
[http://dx.doi.org/10.1101/cshperspect.a011106] [PMID: 23284044]

Nirmala, J.G.; Lopus, M. Cell Death mechanisms in eukaryotes. Cell Biology and Toxicology, 2020, 145-164.
[http://dx.doi.org/10.1007/s10565-019-09496-2]

Oropesa Ávila, M.; Fernández Vega, A.; Garrido Maraver, J.; Villanueva Paz, M.; De Lavera, I.; De La Mata, M.; Cordero, M. D.; Alcocer Gómez, E.; Delgado Pavón, A.; Álvarez Córdoba, M. Emerging roles of apoptotic microtubules during the execution phase of apoptosis. Cytoskeleton, 2015, 435-446.
[http://dx.doi.org/10.1002/cm.21254]

Thiede, B.; Rudel, T. Proteome analysis of apoptotic cells. Mass Spectrom. Rev., 2004, 23(5), 333-349.
[http://dx.doi.org/10.1002/mas.10079] [PMID: 15264233]

Budhidarmo, R.; Day, C.L. IAPs: Modular regulators of cell signalling. Semin. Cell Dev. Biol., 2015, 39, 80-90.
[http://dx.doi.org/10.1016/j.semcdb.2014.12.002] [PMID: 25542341]

Arya, R.; White, K. Cell death in development: Signaling pathways and core mechanisms. Semin. Cell Dev. Biol., 2015, 39, 12-19.
[http://dx.doi.org/10.1016/j.semcdb.2015.02.001] [PMID: 25668151]

Cullen, S.P.; Martin, S.J. Fas and TRAIL ‘death receptors’ as initiators of inflammation: Implications for cancer. Semin. Cell Dev. Biol., 2015, 39, 26-34.
[http://dx.doi.org/10.1016/j.semcdb.2015.01.012] [PMID: 25655947]

Mattick, J.S.; Rinn, J.L. Discovery and annotation of long noncoding RNAs. Nat. Struct. Mol. Biol., 2015, 22(1), 5-7.
[http://dx.doi.org/10.1038/nsmb.2942] [PMID: 25565026]

Uszczynska-Ratajczak, B.; Lagarde, J.; Frankish, A.; Guigó, R.; Johnson, R. Towards a complete map of the human long non-coding RNA transcriptome. Nat. Rev. Genet., 2018, 19(9), 535-548.
[http://dx.doi.org/10.1038/s41576-018-0017-y] [PMID: 29795125]

Erdoğan, İ; Coşacak, M.İ; Nalbant, A.; Akgül, B. Deep sequencing reveals two Jurkat subpopulations with distinct miRNA profiles during camptothecin-induced apoptosis. Derg., 2018, 42(2), 113-122.
[http://dx.doi.org/10.3906/biy-1710-62] [PMID: 30814873]

Yaylak, B.; Erdogan, I.; Akgul, B. Transcriptomics Analysis of Circular RNAs Differentially Expressed in Apoptotic HeLa Cells. Front. Genet., 2019, 10, 176.
[http://dx.doi.org/10.3389/fgene.2019.00176] [PMID: 30918512]

Tüncel, Ö.; Yaylak, B.; Kara, M.; Erdoğan, İ; Akgül, B. Non-Coding RNAs in Apoptosis: Identification and Function. Turk. J. Biol., 2021.
[http://dx.doi.org/10.3906/biy-2109-35]

Worby, C.A.; Dixon, J.E. PTEN. Annu. Rev. Biochem., 2014, 83(1), 641-669.
[http://dx.doi.org/10.1146/annurev-biochem-082411-113907] [PMID: 24905788]

Hafner, A.; Bulyk, M.L.; Jambhekar, A.; Lahav, G. The multiple mechanisms that regulate p53 activity and cell fate. Nat. Rev. Mol. Cell Biol., 2019, 20(4), 199-210.
[http://dx.doi.org/10.1038/s41580-019-0110-x] [PMID: 30824861]

Poliseno, L.; Salmena, L.; Zhang, J.; Carver, B.; Haveman, W.J.; Pandolfi, P.P. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature, 2010, 465(7301), 1033-1038.
[http://dx.doi.org/10.1038/nature09144] [PMID: 20577206]

Johnsson, P.; Ackley, A.; Vidarsdottir, L.; Lui, W-O.; Corcoran, M.; Grandér, D.; Morris, K.V. A pseudogene long-noncoding-RNA network regulates PTEN transcription and translation in human cells. Nat. Struct. Mol. Biol., 2013, 20(4), 440-446.
[http://dx.doi.org/10.1038/nsmb.2516] [PMID: 23435381]

Hall, J.R.; Messenger, Z.J.; Tam, H.W.; Phillips, S.L.; Recio, L.; Smart, R.C. Long noncoding RNA lincRNA-p21 is the major mediator of UVB-induced and p53-dependent apoptosis in keratinocytes. Cell Death Dis., 2015, 6(3), e1700.
[http://dx.doi.org/10.1038/cddis.2015.67] [PMID: 25789975]

Zhang, A.; Zhou, N.; Huang, J.; Liu, Q.; Fukuda, K.; Ma, D.; Lu, Z.; Bai, C.; Watabe, K.; Mo, Y-Y. The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage. Cell Res., 2013, 23(3), 340-350.
[http://dx.doi.org/10.1038/cr.2012.164] [PMID: 23208419]

Peschansky, V.J.; Pastori, C.; Zeier, Z.; Motti, D.; Wentzel, K.; Velmeshev, D.; Magistri, M.; Bixby, J.L.; Lemmon, V.P.; Silva, J.P.; Wahlestedt, C. Changes in expression of the long non-coding RNA FMR4 associate with altered gene expression during differentiation of human neural precursor cells. Front. Genet., 2015, 6, 263.
[http://dx.doi.org/10.3389/fgene.2015.00263] [PMID: 26322075]

Hu, W.; Yuan, B.; Flygare, J.; Lodish, H.F. Long noncoding RNA-mediated anti-apoptotic activity in murine erythroid terminal differentiation. Genes Dev., 2011, 25(24), 2573-2578.
[http://dx.doi.org/10.1101/gad.178780.111] [PMID: 22155924]

Atianand, M.K.; Hu, W.; Satpathy, A.T.; Shen, Y.; Ricci, E.P.; Alvarez-Dominguez, J.R.; Bhatta, A.; Schattgen, S.A.; McGowan, J.D.; Blin, J.; Braun, J.E.; Gandhi, P.; Moore, M.J.; Chang, H.Y.; Lodish, H.F.; Caffrey, D.R.; Fitzgerald, K.A. A Long Noncoding RNA lincRNA-EPS Acts as a Transcriptional Brake to Restrain Inflammation. Cell, 2016, 165(7), 1672-1685.
[http://dx.doi.org/10.1016/j.cell.2016.05.075] [PMID: 27315481]

Geng, X.; Song, N.; Zhao, S.; Xu, J.; Liu, Y.; Fang, Y.; Liang, M.; Xu, X.; Ding, X. LncRNA GAS5 promotes apoptosis as a competing endogenous RNA for miR-21 via thrombospondin 1 in ischemic AKI. Cell Death Discov., 2020, 6(1), 19.
[http://dx.doi.org/10.1038/s41420-020-0253-8] [PMID: 32257391]

Puvvula, P.K.; Desetty, R.D.; Pineau, P.; Marchio, A.; Moon, A.; Dejean, A.; Bischof, O. Long noncoding RNA PANDA and scaffold-attachment-factor SAFA control senescence entry and exit. Nat. Commun., 2014, 5(1), 5323.
[http://dx.doi.org/10.1038/ncomms6323] [PMID: 25406515]

Fu, X.; Ravindranath, L.; Tran, N.; Petrovics, G.; Srivastava, S. Regulation of Apoptosis by a Prostate-Specific and Prostate Cancer- Associated Noncoding Gene, PCGEM1; , 2006, p. 25.
[http://dx.doi.org/10.1089/dna.2006.25.135]

Kim, J.K.; Diehl, J.A. Nuclear cyclin D1: An oncogenic driver in human cancer. J. Cell. Physiol., 2009, 220(2), 292-296.
[http://dx.doi.org/10.1002/jcp.21791] [PMID: 19415697]

Guo, J.Q.; Li, S.J.; Guo, G.X. Long Noncoding RNA AFAP1-AS1 Promotes Cell Proliferation and Apoptosis of Gastric Cancer Cells via PTEN/p-AKT Pathway. Dig. Dis. Sci., 2017, 62(8), 2004-2010.
[http://dx.doi.org/10.1007/s10620-017-4584-0] [PMID: 28451917]

Zhang, J.; Yao, T.; Wang, Y.; Yu, J.; Liu, Y.; Lin, Z. Long noncoding RNA MEG3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by regulating miR-21. Cancer Biol. Ther., 2016, 17(1), 104-113.
[http://dx.doi.org/10.1080/15384047.2015.1108496] [PMID: 26574780]

Khaitan, D.; Dinger, M.E.; Mazar, J.; Crawford, J.; Smith, M.A.; Mattick, J.S.; Perera, R.J. The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion. Cancer Res., 2011, 71(11), 3852-3862.
[http://dx.doi.org/10.1158/0008-5472.CAN-10-4460] [PMID: 21558391]

Gong, Z.; Zhang, S.; Zeng, Z.; Wu, H.; Yang, Q.; Xiong, F.; Shi, L.; Yang, J.; Zhang, W.; Zhou, Y.; Zeng, Y.; Li, X.; Xiang, B.; Peng, S.; Zhou, M.; Li, X.; Tan, M.; Li, Y.; Xiong, W.; Li, G. LOC401317, a p53-regulated long non-coding RNA, inhibits cell proliferation and induces apoptosis in the nasopharyngeal carcinoma cell line HNE2. PLoS One, 2014, 9(11), e110674.
[http://dx.doi.org/10.1371/journal.pone.0110674] [PMID: 25422887]

Yang, Q.; Cui, Z.L.; Wang, Q.; Jin, X.B.; Zhao, Y.; Wang, M.W.; Song, W.; Qu, H.W.; Kang, W.T. PlncRNA-1 Induces Apoptosis through the Her-2 Pathway in Prostate Cancer Cells. Asian J. Androl., 2016, 18.
[http://dx.doi.org/10.4103/1008-682X.178849] [PMID: 27232851]

Chen, T.; Gu, C.; Xue, C.; Yang, T.; Zhong, Y.; Liu, S.; Nie, Y.; Yang, H. LncRNA-uc002mbe.2 Interacting with hnRNPA2B1 Mediates AKT Deactivation and p21 Up-Regulation Induced by Trichostatin in Liver Cancer Cells. Front. Pharmacol., 2017, 8(SEP), 669.
[http://dx.doi.org/10.3389/fphar.2017.00669] [PMID: 28993733]

Zhao, H.; Zhang, X. Frazão, J.B.; Condino-Neto, A.; Newburger, P.E. HOX antisense lincRNA HOXA-AS2 is an apoptosis repressor in all trans retinoic acid treated NB4 promyelocytic leukemia cells. J. Cell. Biochem., 2013, 114(10), 2375-2383.
[http://dx.doi.org/10.1002/jcb.24586] [PMID: 23649634]

Wu, W.; Bhagat, T.D.; Yang, X.; Song, J.H.; Cheng, Y.; Agarwal, R.; Abraham, J.M.; Ibrahim, S.; Bartenstein, M.; Hussain, Z.; Suzuki, M.; Yu, Y.; Chen, W.; Eng, C.; Greally, J.; Verma, A.; Meltzer, S.J. Hypomethylation of noncoding DNA regions and overexpression of the long noncoding RNA, AFAP1-AS1, in Barrett’s esophagus and esophageal adenocarcinoma. Gastroenterology, 2013, 144(5), 956-966.e4.
[http://dx.doi.org/10.1053/j.gastro.2013.01.019] [PMID: 23333711]

Ji, D.; Zhong, X.; Jiang, X.; Leng, K.; Xu, Y.; Li, Z.; Huang, L.; Li, J.; Cui, Y. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors. Pathol. Res. Pract., 2018, 214(10), 1524-1531.
[http://dx.doi.org/10.1016/j.prp.2018.08.014] [PMID: 30173945]

Mazar, J.; Zhao, W.; Khalil, A.M.; Lee, B.; Shelley, J.; Govindarajan, S.S.; Yamamoto, F.; Ratnam, M.; Aftab, M.N.; Collins, S.; Finck, B.N.; Han, X.; Mattick, J.S.; Dinger, M.E.; Perera, R.J. The functional characterization of long noncoding RNA SPRY4-IT1 in human melanoma cells. Oncotarget, 2014, 5(19), 8959-8969.
[http://dx.doi.org/10.18632/oncotarget.1863] [PMID: 25344859]

Gurer, D.C. Erdogan, İ; Ahmadov, U.; Basol, M.; Sweef, O.; Cakan-Akdogan, G.; Akgül, B. Transcriptomics Profiling Identifies Cisplatin-Inducible Death Receptor 5 Antisense Long Non-coding RNA as a Modulator of Proliferation and Metastasis in HeLa Cells. Front. Cell Dev. Biol., 2021, 9, 688855.
[http://dx.doi.org/10.3389/fcell.2021.688855] [PMID: 34497804]

Hong, B.; van den Heuvel, A.P.J.; Prabhu, V.V.; Zhang, S.; El-Deiry, W.S. Targeting tumor suppressor p53 for cancer therapy: Strategies, challenges and opportunities. Curr. Drug Targets, 2014, 15(1), 80-89.
[http://dx.doi.org/10.2174/1389450114666140106101412] [PMID: 24387333]

Hanahan, D.; Weinberg, R.A. The Hallmarks of Cancer Review Evolve Progressively from Normalcy via a Series of Pre, 2000, 100

Hanahan, D.; Weinberg, R.A. Hallmarks of cancer: The next generation. Cell, 2011, 144(5), 646-674.
[http://dx.doi.org/10.1016/j.cell.2011.02.013] [PMID: 21376230]

Wong, R.S.Y. Apoptosis in cancer: From pathogenesis to treatment. J. Exp. Clin. Cancer Res., 2011, 30(1), 87.
[http://dx.doi.org/10.1186/1756-9966-30-87] [PMID: 21943236]

Siddiqui, W.A.; Ahad, A.; Ahsan, H. The mystery of BCL2 family: Bcl-2 proteins and apoptosis: An update. Archives of Toxicology, 2015, 289-317.
[http://dx.doi.org/10.1007/s00204-014-1448-7]

Merino, D.; Lok, S.W.; Visvader, J.E.; Lindeman, G.J. Targeting BCL-2 to enhance vulnerability to therapy in estrogen receptor-positive breast cancer. Oncogene, 2016, 35(15), 1877-1887.
[http://dx.doi.org/10.1038/onc.2015.287] [PMID: 26257067]

Bhan, A.; Soleimani, M.; Mandal, S.S. Long Noncoding RNA and Cancer: A New Paradigm. Cancer Res., 2017, 3965-3981.
[http://dx.doi.org/10.1158/0008-5472.CAN-16-2634]

Hu, X.; Feng, Y.; Zhang, D.; Zhao, S.D.; Hu, Z.; Greshock, J.; Zhang, Y.; Yang, L.; Zhong, X.; Wang, L-P.; Jean, S.; Li, C.; Huang, Q.; Katsaros, D.; Montone, K.T.; Tanyi, J.L.; Lu, Y.; Boyd, J.; Nathanson, K.L.; Li, H.; Mills, G.B.; Zhang, L. A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancer. Cancer Cell, 2014, 26(3), 344-357.
[http://dx.doi.org/10.1016/j.ccr.2014.07.009] [PMID: 25203321]

Huarte, M. The emerging role of lncRNAs in cancer. Nat. Med., 2015, 21(11), 1253-1261.
[http://dx.doi.org/10.1038/nm.3981] [PMID: 26540387]

Carlevaro-Fita, J. Lanzós, A.; Feuerbach, L.; Hong, C.; Mas-Ponte, D.; Pedersen, J.S.; Johnson, R.; Amin, S.B.; Bader, G.D.; Barenboim, J. Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis. Commun. Biol., 2020, 3(1), 56.
[http://dx.doi.org/10.1038/s42003-019-0741-7] [PMID: 32024996]

Bussemakers, M.J.; van Bokhoven, A.; Verhaegh, G.W.; Smit, F.P.; Karthaus, H.F.; Schalken, J.A.; Debruyne, F.M.; Ru, N.; Isaacs, W.B. DD3: A new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res., 1999, 59(23), 5975-5979.
[PMID: 10606244]

Srikantan, V.; Zou, Z.; Petrovics, G.; Xu, L.; Augustus, M.; Davis, L.; Livezey, J. R.; Connell, T.; Sesterhenn, I. A.; Yoshino, K. PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer. Proc. Natl. Acad. Sci., 2000, 97(22), 12216-LP-12221..
[http://dx.doi.org/10.1073/pnas.97.22.12216]

Ji, P.; Diederichs, S.; Wang, W. Böing, S.; Metzger, R.; Schneider, P.M.; Tidow, N.; Brandt, B.; Buerger, H.; Bulk, E.; Thomas, M.; Berdel, W.E.; Serve, H.; Müller-Tidow, C. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene, 2003, 22(39), 8031-8041.
[http://dx.doi.org/10.1038/sj.onc.1206928] [PMID: 12970751]

Gutschner, T. Hämmerle, M.; Diederichs, S. MALAT1 -- a paradigm for long noncoding RNA function in cancer. J. Mol. Med. (Berl.), 2013, 91(7), 791-801.
[http://dx.doi.org/10.1007/s00109-013-1028-y] [PMID: 23529762]

Balas, M.M.; Johnson, A.M. Exploring the mechanisms behind long noncoding RNAs and cancer. Noncoding RNA Research, 2018, 108-117.
[http://dx.doi.org/10.1016/j.ncrna.2018.03.001]

Hajjari, M.; Salavaty, A. HOTAIR: An oncogenic long non-coding RNA in different cancers. Cancer Biol. Med., 2015, 12(1), 1-9.
[http://dx.doi.org/10.7497/j.issn.2095-3941.2015.0006] [PMID: 25859406]

Dong, P.; Xiong, Y.; Yue, J.; Hanley, S.J.B.; Kobayashi, N.; Todo, Y.; Watari, H. Long Non-Coding RNA NEAT1: A Novel Target for Diagnosis and Therapy in Human Tumors. Frontiers in Genetics, 2018.
[http://dx.doi.org/10.3389/fgene.2018.00471]

Choudhry, H.; Albukhari, A.; Morotti, M.; Haider, S.; Moralli, D.; Smythies, J. Schِdel, J.; Green, C.M.; Camps, C.; Buffa, F.; Ratcliffe, P.; Ragoussis, J.; Harris, A.L.; Mole, D.R. Tumor hypoxia induces nuclear paraspeckle formation through HIF-2α dependent transcriptional activation of NEAT1 leading to cancer cell survival. Oncogene, 2015, 34(34), 4482-4490.
[http://dx.doi.org/10.1038/onc.2014.378] [PMID: 25417700]

Chen, Q.; Cai, J.; Wang, Q.; Wang, Y.; Liu, M.; Yang, J.; Zhou, J.; Kang, C.; Li, M.; Jiang, C. Long Noncoding RNA NEAT1, Regulated by the EGFR Pathway, Contributes to Glioblastoma Progression Through the WNT/β-Catenin Pathway by Scaffolding EZH2. Clin. Cancer Res., 2018, 24(3), 684-695.
[http://dx.doi.org/10.1158/1078-0432.CCR-17-0605] [PMID: 29138341]

Wang, J.; Zhao, X.; Guo, Z.; Ma, X.; Song, Y.; Guo, Y. Regulation of NEAT1/miR-214-3p on the growth, migration and invasion of endometrial carcinoma cells. Arch. Gynecol. Obstet., 2017, 295(6), 1469-1475.
[http://dx.doi.org/10.1007/s00404-017-4365-1] [PMID: 28447190]

Xia, T.; Chen, S.; Jiang, Z.; Shao, Y.; Jiang, X.; Li, P.; Xiao, B.; Guo, J. Long noncoding RNA FER1L4 suppresses cancer cell growth by acting as a competing endogenous RNA and regulating PTEN expression. Sci. Rep., 2015, 5(1), 13445.
[http://dx.doi.org/10.1038/srep13445] [PMID: 26306906]

Lin, A.; Li, C.; Xing, Z.; Hu, Q.; Liang, K.; Han, L.; Wang, C.; Hawke, D.H.; Wang, S.; Zhang, Y.; Wei, Y.; Ma, G.; Park, P.K.; Zhou, J.; Zhou, Y.; Hu, Z.; Zhou, Y.; Marks, J.R.; Liang, H.; Hung, M.C.; Lin, C.; Yang, L. The LINK-A lncRNA activates normoxic HIF1α signalling in triple-negative breast cancer. Nat. Cell Biol., 2016, 18(2), 213-224.
[http://dx.doi.org/10.1038/ncb3295] [PMID: 26751287]

Wang, Z.; Jin, Y.; Ren, H.; Ma, X.; Wang, B.; Wang, Y. Downregulation of the long non-coding RNA TUSC7 promotes NSCLC cell proliferation and correlates with poor prognosis. Am. J. Transl. Res., 2016, 8(2), 680-687.
[PMID: 27158360]

Wang, L.; Han, S.; Jin, G.; Zhou, X.; Li, M.; Ying, X.; Wang, L.; Wu, H.; Zhu, Q. Linc00963: A novel, long non-coding RNA involved in the transition of prostate cancer from androgen-dependence to androgen-independence. Int. J. Oncol., 2014, 44(6), 2041-2049.
[http://dx.doi.org/10.3892/ijo.2014.2363] [PMID: 24691949]

Fei, Z-H.; Yu, X-J.; Zhou, M.; Su, H-F.; Zheng, Z.; Xie, C-Y. Upregulated expression of long non-coding RNA LINC00982 regulates cell proliferation and its clinical relevance in patients with gastric cancer. Tumour Biol., 2016, 37(2), 1983-1993.
[http://dx.doi.org/10.1007/s13277-015-3979-9] [PMID: 26334618]

Su, H.; Sun, T.; Wang, H.; Shi, G.; Zhang, H.; Sun, F.; Ye, D. Decreased TCL6 expression is associated with poor prognosis in patients with clear cell renal cell carcinoma. Oncotarget, 2017, 8(4), 5789-5799.
[http://dx.doi.org/10.18632/oncotarget.11011] [PMID: 27494890]

Qi, P.; Xu, M.D.; Ni, S.J.; Shen, X.H.; Wei, P.; Huang, D.; Tan, C.; Sheng, W.Q.; Zhou, X.Y.; Du, X. Down-regulation of ncRAN, a long non-coding RNA, contributes to colorectal cancer cell migration and invasion and predicts poor overall survival for colorectal cancer patients. Mol. Carcinog., 2015, 54(9), 742-750.
[http://dx.doi.org/10.1002/mc.22137] [PMID: 24519959]

Vučićević D.; Gehre, M.; Dhamija, S.; Friis-Hansen, L.; Meierhofer, D.; Sauer, S.; Ørom, U.A. The long non-coding RNA PARROT is an upstream regulator of c-Myc and affects proliferation and translation. Oncotarget, 2016, 7(23), 33934-33947.
[http://dx.doi.org/10.18632/oncotarget.8985] [PMID: 27129154]

Schmidt, K.; Joyce, C.E.; Buquicchio, F.; Brown, A.; Ritz, J.; Distel, R.J.; Yoon, C.H.; Novina, C.D. The lncRNA SLNCR1 Mediates Melanoma Invasion through a Conserved SRA1-like Region. Cell Rep., 2016, 15(9), 2025-2037.
[http://dx.doi.org/10.1016/j.celrep.2016.04.018] [PMID: 27210747]

Liu, P.Y.; Erriquez, D.; Marshall, G.M.; Tee, A.E.; Polly, P.; Wong, M.; Liu, B.; Bell, J.L.; Zhang, X.D.; Milazzo, G.; Cheung, B.B.; Fox, A.; Swarbrick, A.; Hüttelmaier, S.; Kavallaris, M.; Perini, G.; Mattick, J.S.; Dinger, M.E.; Liu, T. Effects of a novel long noncoding RNA, lncUSMycN, on N-Myc expression and neuroblastoma progression. J. Natl. Cancer Inst., 2014, 106(7), dju113.
[http://dx.doi.org/10.1093/jnci/dju113] [PMID: 24906397]

Mertens, D.; Philippen, A.; Ruppel, M.; Allegra, D.; Bhattacharya, N.; Tschuch, C.; Wolf, S.; Idler, I.; Zenz, T.; Stilgenbauer, S. Chronic lymphocytic leukemia and 13q14: MiRs and more. Leuk. Lymphoma, 2009, 50(3), 502-505.
[http://dx.doi.org/10.1080/10428190902763509] [PMID: 19347735]

Qi, H-L.; Li, C-S.; Qian, C-W.; Xiao, Y-S.; Yuan, Y-F.; Liu, Q-Y.; Liu, Z-S. The long noncoding RNA, EGFR-AS1, a target of GHR, increases the expression of EGFR in hepatocellular carcinoma. Tumour Biol., 2016, 37(1), 1079-1089.
[http://dx.doi.org/10.1007/s13277-015-3887-z] [PMID: 26271667]

Li, Z.; Zhang, J.; Liu, X.; Li, S.; Wang, Q. Di Chen; Hu, Z.; Yu, T.; Ding, J.; Li, J.; Yao, M.; Fan, J.; Huang, S.; Gao, Q.; Zhao, Y.; He, X. The LINC01138 drives malignancies via activating arginine methyltransferase 5 in hepatocellular carcinoma. Nat. Commun., 2018, 9(1), 1572.
[http://dx.doi.org/10.1038/s41467-018-04006-0] [PMID: 29679004]

Sassenberg, M.; Droop, J.; Schulz, W.A.; Dietrich, D.; Loick, S.M.; Wiek, C.; Scheckenbach, K.; Gaisa, N.T.; Hoffmann, M.J. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma. BMC Cancer, 2019, 19(1), 806.
[http://dx.doi.org/10.1186/s12885-019-6021-6] [PMID: 31412811]

Mao, H.; Wang, K.; Feng, Y.; Zhang, J.; Pan, L.; Zhan, Y.; Sheng, H.; Luo, G. Prognostic role of long non-coding RNA XIST expression in patients with solid tumors: A meta-analysis. Cancer Cell Int., 2018, 18(1), 34.
[http://dx.doi.org/10.1186/s12935-018-0535-x] [PMID: 29556138]

Bao, J.; Chen, X.; Hou, Y.; Kang, G.; Li, Q.; Xu, Y. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway. Biomed. Pharmacother., 2018, 107, 824-833.
[http://dx.doi.org/10.1016/j.biopha.2018.08.079] [PMID: 30142544]

Zhu, Y.; Liu, B.; Zhang, P.; Zhang, J.; Wang, L. LncRNA TUSC8 inhibits the invasion and migration of cervical cancer cells via miR-641/PTEN axis. Cell Biol. Int., 2019, 43(7), 781-788.
[http://dx.doi.org/10.1002/cbin.11152] [PMID: 31033083]

Jin, S-J.; Jin, M-Z.; Xia, B-R.; Jin, W-L. Long Non-coding RNA DANCR as an Emerging Therapeutic Target in Human Cancers. Front. Oncol., 2019, 9, 1225.
[http://dx.doi.org/10.3389/fonc.2019.01225] [PMID: 31799189]

Xie, H-W.; Wu, Q-Q.; Zhu, B.; Chen, F-J.; Ji, L.; Li, S-Q.; Wang, C-M.; Tong, Y-S.; Tuo, L.; Wu, M.; Liu, Z.H.; Lv, J.; Shi, W.H.; Cao, X.F. Long noncoding RNA SPRY4-IT1 is upregulated in esophageal squamous cell carcinoma and associated with poor prognosis. Tumour Biol., 2014, 35(8), 7743-7754.
[http://dx.doi.org/10.1007/s13277-014-2013-y] [PMID: 24810925]

Li, Y.; Luo, H.; Xiao, N.; Duan, J.; Wang, Z.; Wang, S. Long Noncoding RNA SChLAP1 Accelerates the Proliferation and Metastasis of Prostate Cancer via Targeting miR-198 and Promoting the MAPK1 Pathway. Oncol. Res., 2018, 26(1), 131-143.
[http://dx.doi.org/10.3727/096504017X14944585873631] [PMID: 28492138]

Qiu, M.; Xu, Y.; Wang, J.; Zhang, E.; Sun, M.; Zheng, Y.; Li, M.; Xia, W.; Feng, D.; Yin, R.; Xu, L. A novel lncRNA, LUADT1, promotes lung adenocarcinoma proliferation via the epigenetic suppression of p27. Cell Death Dis., 2015, 6(8), e1858.
[http://dx.doi.org/10.1038/cddis.2015.203] [PMID: 26291312]

Yuan, H.; Qin, Y.; Zeng, B.; Feng, Y.; Li, Y.; Xiang, T.; Ren, G. Long noncoding RNA LINC01089 predicts clinical prognosis and inhibits cell proliferation and invasion through the Wnt/β-catenin signaling pathway in breast cancer. OncoTargets Ther., 2019, 12, 4883-4895.
[http://dx.doi.org/10.2147/OTT.S208830] [PMID: 31417284]

Zhang, Q.; Len, T-Y.; Zhang, S-X.; Zhao, Q-H.; Yang, L-H. Exosomes transferring long non-coding RNA FAL1 to regulate ovarian cancer metastasis through the PTEN/AKT signaling pathway. Eur. Rev. Med. Pharmacol. Sci., 2020, 24(1), 43-54.
[http://dx.doi.org/10.26355/eurrev_202001_19894] [PMID: 31957817]

Yu, W.; Qiao, Y.; Tang, X.; Ma, L.; Wang, Y.; Zhang, X.; Weng, W.; Pan, Q.; Yu, Y.; Sun, F.; Wang, J. Tumor suppressor long non-coding RNA, MT1DP is negatively regulated by YAP and Runx2 to inhibit FoxA1 in liver cancer cells. Cell. Signal., 2014, 26(12), 2961-2968.
[http://dx.doi.org/10.1016/j.cellsig.2014.09.011] [PMID: 25261601]

Li, W.; Li, Y.; Zhang, H.; Liu, M.; Gong, H.; Yuan, Y.; Shi, R.; Zhang, Z.; Liu, C.; Chen, C.; Liu, H.; Chen, J. HOTAIR promotes gefitinib resistance through modification of EZH2 and silencing p16 and p21 in non-small cell lung cancer. J. Cancer, 2021, 12(18), 5562-5572.
[http://dx.doi.org/10.7150/jca.56093] [PMID: 34405017]

Yan, M.; Zhang, L.; Li, G.; Xiao, S.; Dai, J.; Cen, X. Long noncoding RNA linc-ITGB1 promotes cell migration and invasion in human breast cancer. Biotechnol. Appl. Biochem., 2017, 64(1), 5-13.
[http://dx.doi.org/10.1002/bab.1461] [PMID: 26601916]

Wang, Y.; Chen, W.; Yang, C.; Wu, W.; Wu, S.; Qin, X.; Li, X. Long non-coding RNA UCA1a(CUDR) promotes proliferation and tumorigenesis of bladder cancer. Int. J. Oncol., 2012, 41(1), 276-284.
[http://dx.doi.org/10.3892/ijo.2012.1443] [PMID: 22576688]

Marques Howarth, M.; Simpson, D.; Ngok, S.P.; Nieves, B.; Chen, R.; Siprashvili, Z.; Vaka, D.; Breese, M.R.; Crompton, B.D.; Alexe, G.; Hawkins, D.S.; Jacobson, D.; Brunner, A.L.; West, R.; Mora, J.; Stegmaier, K.; Khavari, P.; Sweet-Cordero, E.A. Long noncoding RNA EWSAT1-mediated gene repression facilitates Ewing sarcoma oncogenesis. J. Clin. Invest., 2014, 124(12), 5275-5290.
[http://dx.doi.org/10.1172/JCI72124] [PMID: 25401475]

Visnovsky, J.; Kudela, E.; Farkasova, A.; Balharek, T.; Krkoska, M.; Danko, J. Amplification of TERT and TERC genes in cervical intraepithelial neoplasia and cervical cancer. Neuroendocrinol. Lett., 2014, 35(6), 518-522.
[PMID: 25433838]

Hu, G.; Yang, T.; Zheng, J.; Dai, J.; Nan, A.; Lai, Y.; Zhang, Y.; Yang, C.; Jiang, Y. Functional role and mechanism of lncRNA LOC728228 in malignant 16HBE cells transformed by anti-benzopyrene-trans-7,8-dihydrodiol-9,10-epoxide. Mol. Carcinog., 2015, 54(S1)(Suppl. 1), E192-E204.
[http://dx.doi.org/10.1002/mc.22314] [PMID: 25820656]

Chen, W.; Li, Y.; Guo, L.; Zhang, C.; Tang, S. Long non-coding RNA FTX predicts a poor prognosis of human cancers: A meta-analysis. Biosci. Rep., 2021, 41(1), BSR20203995.
[http://dx.doi.org/10.1042/BSR20203995] [PMID: 33398336]

Emmrich, S.; Streltsov, A.; Schmidt, F.; Thangapandi, V.R.; Reinhardt, D.; Klusmann, J-H. LincRNAs MONC and MIR100HG act as oncogenes in acute megakaryoblastic leukemia. Mol. Cancer, 2014, 13(1), 171.
[http://dx.doi.org/10.1186/1476-4598-13-171] [PMID: 25027842]

Tu, C.; Ren, X.; He, J.; Zhang, C.; Chen, R.; Wang, W.; Li, Z. The Value of LncRNA BCAR4 as a Prognostic Biomarker on Clinical Outcomes in Human Cancers. J. Cancer, 2019, 10(24), 5992-6002.
[http://dx.doi.org/10.7150/jca.35113] [PMID: 31762809]

Marín-Béjar, O.; Mas, A.M.; González, J.; Martinez, D.; Athie, A.; Morales, X.; Galduroz, M.; Raimondi, I.; Grossi, E.; Guo, S.; Rouzaut, A.; Ulitsky, I.; Huarte, M. The human lncRNA LINC-PINT inhibits tumor cell invasion through a highly conserved sequence element. Genome Biol., 2017, 18(1), 202.
[http://dx.doi.org/10.1186/s13059-017-1331-y] [PMID: 29078818]

Yang, X.; Miao, S.; Mao, X.; Xiu, C.; Sun, J.; Pei, R.; Jia, S. LncRNA LINC-PINT Inhibits Malignant Behaviors of Laryngeal Squamous Cell Carcinoma Cells via Inhibiting ZEB1. Pathol. Oncol. Res., 2021, 27, 584466.
[http://dx.doi.org/10.3389/pore.2021.584466] [PMID: 34257531]

Han, X.; Liu, J.; Liu, Y.; Mou, L.; Li, C. LINC-PINT Inhibited Malignant Progression of Bladder Cancer by Targeting miR-155-5p. Cancer Manag. Res., 2021, 13, 4393-4401.
[http://dx.doi.org/10.2147/CMAR.S305547] [PMID: 34103994]

Sun, N.X.; Ye, C.; Zhao, Q.; Zhang, Q.; Xu, C.; Wang, S.B.; Jin, Z.J.; Sun, S.H.; Wang, F.; Li, W. Long noncoding RNA-EBIC promotes tumor cell invasion by binding to EZH2 and repressing E-cadherin in cervical cancer. PLoS One, 2014, 9(7), e100340.
[http://dx.doi.org/10.1371/journal.pone.0100340] [PMID: 25007342]

Dong, B.; Chen, X.; Zhang, Y.; Zhu, C.; Dong, Q. The prognostic value of lncRNA SNHG1 in cancer patients: A meta-analysis. BMC Cancer, 2019, 19(1), 780.
[http://dx.doi.org/10.1186/s12885-019-5987-4] [PMID: 31391030]

Shi, T.; Guo, D.; Xu, H.; Su, G.; Chen, J.; Zhao, Z.; Shi, J.; Wedemeyer, M.; Attenello, F.; Zhang, L.; Lu, W. HOTAIRM1, an enhancer lncRNA, promotes glioma proliferation by regulating long-range chromatin interactions within HOXA cluster genes. Mol. Biol. Rep., 2020, 47(4), 2723-2733.
[http://dx.doi.org/10.1007/s11033-020-05371-0] [PMID: 32180085]

Crea, F.; Watahiki, A.; Quagliata, L.; Xue, H.; Pikor, L.; Parolia, A.; Wang, Y.; Lin, D.; Lam, W.L.; Farrar, W.L.; Isogai, T.; Morant, R.; Castori-Eppenberger, S.; Chi, K.N.; Wang, Y.; Helgason, C.D. Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer. Oncotarget, 2014, 5(3), 764-774.
[http://dx.doi.org/10.18632/oncotarget.1769] [PMID: 24519926]

Xu, T-P.; Huang, M.D.; Xia, R.; Liu, X-X.; Sun, M.; Yin, L.; Chen, W-M.; Han, L.; Zhang, E-B.; Kong, R.; De, W.; Shu, Y.Q. Decreased expression of the long non-coding RNA FENDRR is associated with poor prognosis in gastric cancer and FENDRR regulates gastric cancer cell metastasis by affecting fibronectin1 expression. J. Hematol. Oncol., 2014, 7(1), 63.
[http://dx.doi.org/10.1186/s13045-014-0063-7] [PMID: 25167886]

Xu, W.; Wang, B.; Cai, Y.; Chen, J.; Meng, E.; Guo, C.; Zhou, G.; Yuan, C. The Therapeutic Value and Molecular Mechanisms of lncRNA FENDRR in Human Cancer. Curr. Pharm. Des., 2021, 27(39), 4100-4106.
[http://dx.doi.org/10.2174/1381612827666210820094702] [PMID: 34414867]

Qiu, S.; Chen, G.; Peng, J.; Liu, J.; Chen, J.; Wang, J.; Li, L.; Yang, K. LncRNA EGOT decreases breast cancer cell viability and migration via inactivation of the Hedgehog pathway. FEBS Open Bio, 2020, 10(5), 817-826.
[http://dx.doi.org/10.1002/2211-5463.12833] [PMID: 32150666]

Dong, D.; Mu, Z.; Zhao, C.; Sun, M. ZFAS1: A novel tumor-related long non-coding RNA. Cancer Cell Int., 2018, 18(1), 125.
[http://dx.doi.org/10.1186/s12935-018-0623-y] [PMID: 30186041]

Cai, H.; Ye, X.; He, B.; Li, Q.; Li, Y.; Gao, Y. LncRNA-AP001631.9 promotes cell migration in gastric cancer. Int. J. Clin. Exp. Pathol., 2015, 8(6), 6235-6244.
[PMID: 26261500]

Yin, Y.; Zhao, B.; Li, D.; Yin, G. Long non-coding RNA CASC15 promotes melanoma progression by epigenetically regulating PDCD4. Cell Biosci., 2018, 8(1), 42.
[http://dx.doi.org/10.1186/s13578-018-0240-4] [PMID: 30013768]

Hou, L.; Tu, J.; Cheng, F.; Yang, H.; Yu, F.; Wang, M.; Liu, J.; Fan, J.; Zhou, G. Long noncoding RNA ROR promotes breast cancer by regulating the TGF-β pathway. Cancer Cell Int., 2018, 18(1), 142.
[http://dx.doi.org/10.1186/s12935-018-0638-4] [PMID: 30250400]

Lv, L.; Chen, G.; Zhou, J.; Li, J.; Gong, J. WT1-AS promotes cell apoptosis in hepatocellular carcinoma through down-regulating of WT1. J. Exp. Clin. Cancer Res., 2015, 34(1), 119.
[http://dx.doi.org/10.1186/s13046-015-0233-7] [PMID: 26462627]

Birgani, M.T.; Hajjari, M.; Shahrisa, A.; Khoshnevisan, A.; Shoja, Z.; Motahari, P.; Farhangi, B. Long Non-Coding RNA SNHG6 as a Potential Biomarker for Hepatocellular Carcinoma. Pathol. Oncol. Res., 2018, 24(2), 329-337.
[http://dx.doi.org/10.1007/s12253-017-0241-3] [PMID: 28508329]

Chen, R.; Cheng, Q.; Owusu-Ansah, K.G.; Song, G.; Jiang, D.; Zhou, L.; Xu, X.; Wu, J.; Zheng, S. NKILA, a prognostic indicator, inhibits tumor metastasis by suppressing NF-κB/Slug mediated epithelial-mesenchymal transition in hepatocellular carcinoma. Int. J. Biol. Sci., 2020, 16(3), 495-503.
[http://dx.doi.org/10.7150/ijbs.39582] [PMID: 32015685]

Dong, X.; Fang, Z.; Yu, M.; Zhang, L.; Xiao, R.; Li, X.; Pan, G.; Liu, J. Knockdown of Long Noncoding RNA HOXA-AS2 Suppresses Chemoresistance of Acute Myeloid Leukemia via the miR-520c-3p/S100A4 Axis. Cell. Physiol. Biochem., 2018, 51(2), 886-896.
[http://dx.doi.org/10.1159/000495387] [PMID: 30466095]

Liu, X-F.; Hao, J-L.; Xie, T.; Pant, O.P.; Lu, C-B.; Lu, C-W.; Zhou, D-D. The BRAF activated non-coding RNA: A pivotal long non-coding RNA in human malignancies. Cell Prolif., 2018, 51(4), e12449-e12449.
[http://dx.doi.org/10.1111/cpr.12449] [PMID: 29484737]

Yang, X.; Song, J.H.; Cheng, Y.; Wu, W.; Bhagat, T.; Yu, Y.; Abraham, J.M.; Ibrahim, S.; Ravich, W.; Roland, B.C.; Khashab, M.; Singh, V.K.; Shin, E.J.; Yang, X.; Verma, A.K.; Meltzer, S.J.; Mori, Y. Long non-coding RNA HNF1A-AS1 regulates proliferation and migration in oesophageal adenocarcinoma cells. Gut, 2014, 63(6), 881-890.
[http://dx.doi.org/10.1136/gutjnl-2013-305266] [PMID: 24000294]

Ylipää, A.; Kivinummi, K.; Kohvakka, A.; Annala, M.; Latonen, L.; Scaravilli, M.; Kartasalo, K.; Leppänen, S-P.; Karakurt, S.; Seppälä, J.; Yli-Harja, O.; Tammela, T.L.; Zhang, W.; Visakorpi, T.; Nykter, M. Transcriptome Sequencing Reveals PCAT5 as a Novel ERG-Regulated Long Noncoding RNA in Prostate Cancer. Cancer Res., 2015, 75(19), 4026-4031.
[http://dx.doi.org/10.1158/0008-5472.CAN-15-0217] [PMID: 26282172]

Yao, J.; Zhou, B.; Zhang, J.; Geng, P.; Liu, K.; Zhu, Y.; Zhu, W. A new tumor suppressor LncRNA ADAMTS9-AS2 is regulated by DNMT1 and inhibits migration of glioma cells. Tumour Biol., 2014, 35(8), 7935-7944.
[http://dx.doi.org/10.1007/s13277-014-1949-2] [PMID: 24833086]

Pan, F.; Yao, J.; Chen, Y.; Zhou, C.; Geng, P.; Mao, H.; Fang, X. A novel long non-coding RNA FOXCUT and mRNA FOXC1 pair promote progression and predict poor prognosis in esophageal squamous cell carcinoma. Int. J. Clin. Exp. Pathol., 2014, 7(6), 2838-2849.
[PMID: 25031703]

Chen, S-X.; Yin, J-F.; Lin, B-C.; Su, H-F.; Zheng, Z.; Xie, C-Y.; Fei, Z-H. Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC. Tumour Biol., 2016, 37(5), 6801-6812.
[http://dx.doi.org/10.1007/s13277-015-4404-0] [PMID: 26662309]

Sun, Y-F.; Wang, Y.; Li, X-D.; Wang, H. SNHG15, a P53-regulated LncRNA, suppresses cisplatin-induced apoptosis and ROS accumulation through the MiR-335-3p/ZNF32 Axis. Am. J. Cancer Res., 2022, 12(2), 816-828.

Takayama, K.; Horie-Inoue, K.; Katayama, S.; Suzuki, T.; Tsutsumi, S.; Ikeda, K.; Urano, T.; Fujimura, T.; Takagi, K.; Takahashi, S.; Homma, Y.; Ouchi, Y.; Aburatani, H.; Hayashizaki, Y.; Inoue, S. Androgen-responsive long noncoding RNA CTBP1-AS promotes prostate cancer. EMBO J., 2013, 32(12), 1665-1680.
[http://dx.doi.org/10.1038/emboj.2013.99] [PMID: 23644382]

Leucci, E.; Vendramin, R.; Spinazzi, M.; Laurette, P.; Fiers, M.; Wouters, J.; Radaelli, E.; Eyckerman, S.; Leonelli, C.; Vanderheyden, K.; Rogiers, A.; Hermans, E.; Baatsen, P.; Aerts, S.; Amant, F.; Van Aelst, S.; van den Oord, J.; de Strooper, B.; Davidson, I.; Lafontaine, D.L.; Gevaert, K.; Vandesompele, J.; Mestdagh, P.; Marine, J.C. Melanoma addiction to the long non-coding RNA SAMMSON. Nature, 2016, 531(7595), 518-522.
[http://dx.doi.org/10.1038/nature17161] [PMID: 27008969]

Ghafouri-Fard, S.; Dashti, S.; Taheri, M. The HOTTIP (HOXA transcript at the distal tip) lncRNA: Review of oncogenic roles in human. Biomed. Pharmacother., 2020, 127, 110158.
[http://dx.doi.org/10.1016/j.biopha.2020.110158] [PMID: 32335298]

Li, L-J.; Zhu, J-L.; Bao, W-S.; Chen, D-K.; Huang, W-W.; Weng, Z-L. Long noncoding RNA GHET1 promotes the development of bladder cancer. Int. J. Clin. Exp. Pathol., 2014, 7(10), 7196-7205.
[PMID: 25400817]

Silva, J.M.; Boczek, N.J.; Berres, M.W.; Ma, X.; Smith, D.I. LSINCT5 is over expressed in breast and ovarian cancer and affects cellular proliferation. RNA Biol., 2011, 8(3), 496-505.
[http://dx.doi.org/10.4161/rna.8.3.14800] [PMID: 21532345]

Henry, W.S.; Hendrickson, D.G.; Beca, F.; Glass, B.; Lindahl-Allen, M.; He, L.; Ji, Z.; Struhl, K.; Beck, A.H.; Rinn, J.L.; Toker, A. LINC00520 is induced by Src, STAT3, and PI3K and plays a functional role in breast cancer. Oncotarget, 2016, 7(50), 81981-81994.
[http://dx.doi.org/10.18632/oncotarget.11962] [PMID: 27626181]

Wan, X.; Huang, W.; Yang, S.; Zhang, Y.; Pu, H.; Fu, F.; Huang, Y.; Wu, H.; Li, T.; Li, Y. Identification of androgen-responsive lncRNAs as diagnostic and prognostic markers for prostate cancer. Oncotarget, 2016, 7(37), 60503-60518.
[http://dx.doi.org/10.18632/oncotarget.11391] [PMID: 27556357]

Atmadibrata, B.; Liu, P.Y.; Sokolowski, N.; Zhang, L.; Wong, M.; Tee, A.E.; Marshall, G.M.; Liu, T. The novel long noncoding RNA linc00467 promotes cell survival but is down-regulated by N-Myc. PLoS One, 2014, 9(2), e88112.
[http://dx.doi.org/10.1371/journal.pone.0088112] [PMID: 24586304]

Dai, M.; Li, S.; Qin, X. Colorectal neoplasia differentially expressed: A long noncoding RNA with an imperative role in cancer. OncoTargets Ther., 2018, 11, 3755-3763.
[http://dx.doi.org/10.2147/OTT.S162754] [PMID: 29988699]

Kaller, M.; Götz, U.; Hermeking, H. Loss of p53-inducible long non-coding RNA LINC01021 increases chemosensitivity. Oncotarget, 2017, 8(61), 102783-102800.
[http://dx.doi.org/10.18632/oncotarget.22245] [PMID: 29262524]

Saha, S.; Kiran, M.; Kuscu, C.; Chatrath, A.; Wotton, D.; Mayo, M.W.; Dutta, A. Long Noncoding RNA DRAIC Inhibits Prostate Cancer Progression by Interacting with IKK to Inhibit NF-κB Activation. Cancer Res., 2020, 80(5), 950-963.
[http://dx.doi.org/10.1158/0008-5472.CAN-19-3460] [PMID: 31900260]

Wang, X.; Lu, X.; Geng, Z.; Yang, G.; Shi, Y. LncRNA PTCSC3/miR-574-5p Governs Cell Proliferation and Migration of Papillary Thyroid Carcinoma via Wnt/β-Catenin Signaling. J. Cell. Biochem., 2017, 118(12), 4745-4752.
[http://dx.doi.org/10.1002/jcb.26142] [PMID: 28513866]

Zhang, L.; Zhou, X-F.; Pan, G-F.; Zhao, J-P. Enhanced expression of long non-coding RNA ZXF1 promoted the invasion and metastasis in lung adenocarcinoma. Biomed. Pharmacother., 2014, 68(4), 401-407.
[http://dx.doi.org/10.1016/j.biopha.2014.03.001] [PMID: 24721325]

Malik, R.; Patel, L.; Prensner, J.R.; Shi, Y.; Iyer, M.K.; Subramaniyan, S.; Carley, A.; Niknafs, Y.S.; Sahu, A.; Han, S.; Ma, T.; Liu, M.; Asangani, I.A.; Jing, X.; Cao, X.; Dhanasekaran, S.M.; Robinson, D.R.; Feng, F.Y.; Chinnaiyan, A.M. The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer. Mol. Cancer Res., 2014, 12(8), 1081-1087.
[http://dx.doi.org/10.1158/1541-7786.MCR-14-0257] [PMID: 25030374]

Gao, X.; Wen, J.; Gao, P.; Zhang, G.; Zhang, G. Overexpression of the long non-coding RNA, linc-UBC1, is associated with poor prognosis and facilitates cell proliferation, migration, and invasion in colorectal cancer. OncoTargets Ther., 2017, 10, 1017-1026.
[http://dx.doi.org/10.2147/OTT.S129343] [PMID: 28260919]

Tang, J.; Zhuo, H.; Zhang, X.; Jiang, R.; Ji, J.; Deng, L.; Qian, X.; Zhang, F.; Sun, B. A novel biomarker Linc00974 interacting with KRT19 promotes proliferation and metastasis in hepatocellular carcinoma. Cell Death Dis., 2014, 5(12), e1549-e1549.
[http://dx.doi.org/10.1038/cddis.2014.518] [PMID: 25476897]

Wu, J.; Zhang, J.; Shen, B.; Yin, K.; Xu, J.; Gao, W.; Zhang, L. Long noncoding RNA lncTCF7, induced by IL-6/STAT3 transactivation, promotes hepatocellular carcinoma aggressiveness through epithelial-mesenchymal transition. J. Exp. Clin. Cancer Res., 2015, 34(1), 116.
[http://dx.doi.org/10.1186/s13046-015-0229-3] [PMID: 26452542]

Wang, T.H.; Lin, Y.S.; Chen, Y.; Yeh, C.T.; Huang, Y.L.; Hsieh, T.H.; Shieh, T.M.; Hsueh, C.; Chen, T.C. Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition. Oncotarget, 2015, 6(27), 23342-23357.
[http://dx.doi.org/10.18632/oncotarget.4344] [PMID: 26160837]

Wei, G.; Luo, H.; Sun, Y.; Li, J.; Tian, L.; Liu, W.; Liu, L.; Luo, J.; He, J.; Chen, R. Transcriptome profiling of esophageal squamous cell carcinoma reveals a long noncoding RNA acting as a tumor suppressor. Oncotarget, 2015, 6(19), 17065-17080.
[http://dx.doi.org/10.18632/oncotarget.4185] [PMID: 26158411]

Xue, S.; Li, Q-W.; Che, J-P.; Guo, Y.; Yang, F-Q.; Zheng, J-H. Decreased expression of long non-coding RNA NBAT-1 is associated with poor prognosis in patients with clear cell renal cell carcinoma. Int. J. Clin. Exp. Pathol., 2015, 8(4), 3765-3774.
[PMID: 26097558]

Yu, Y.; Li, L.; Zheng, Z.; Chen, S.; Chen, E.; Hu, Y. Long non-coding RNA linc00261 suppresses gastric cancer progression via promoting Slug degradation. J. Cell. Mol. Med., 2017, 21(5), 955-967.
[http://dx.doi.org/10.1111/jcmm.13035] [PMID: 27878953]

Zhu, K-P.; Ma, X-L.; Zhang, C-L. LncRNA ODRUL Contributes to Osteosarcoma Progression through the miR-3182/MMP2 Axis. Mol. Ther., 2017, 25(10), 2383-2393.
[http://dx.doi.org/10.1016/j.ymthe.2017.06.027] [PMID: 28750740]

Onagoruwa, O.T.; Pal, G.; Ochu, C.; Ogunwobi, O.O. Oncogenic Role of PVT1 and Therapeutic Implications. Front. Oncol., 2020, 10, 17.
[http://dx.doi.org/10.3389/fonc.2020.00017] [PMID: 32117705]

Kawasaki, Y.; Komiya, M.; Matsumura, K.; Negishi, L.; Suda, S.; Okuno, M.; Yokota, N.; Osada, T.; Nagashima, T.; Hiyoshi, M.; Okada-Hatakeyama, M.; Kitayama, J.; Shirahige, K.; Akiyama, T. MYU, a Target lncRNA for Wnt/c-Myc Signaling, Mediates Induction of CDK6 to Promote Cell Cycle Progression. Cell Rep., 2016, 16(10), 2554-2564.
[http://dx.doi.org/10.1016/j.celrep.2016.08.015] [PMID: 27568568]

Zeng, X.; Sikka, S.C.; Huang, L.; Sun, C.; Xu, C.; Jia, D.; Abdel-Mageed, A.B.; Pottle, J.E.; Taylor, J.T.; Li, M. Novel role for the transient receptor potential channel TRPM2 in prostate cancer cell proliferation. Prostate Cancer Prostatic Dis., 2010, 13(2), 195-201.
[http://dx.doi.org/10.1038/pcan.2009.55] [PMID: 20029400]

Ghafouri-Fard, S.; Dashti, S.; Taheri, M.; Omrani, M.D. TINCR: An lncRNA with dual functions in the carcinogenesis process. Noncoding RNA Research, 2020, 5(3), 109-115.
[http://dx.doi.org/10.1016/j.ncrna.2020.06.003] [PMID: 32695943]

Cardoso, C.; Serafim, R.B.; Kawakami, A.; Gonçalves Pereira, C.; Roszik, J.; Valente, V.; Vazquez, V.L.; Fisher, D.E.; Espreafico, E.M. The lncRNA RMEL3 protects immortalized cells from serum withdrawal-induced growth arrest and promotes melanoma cell proliferation and tumor growth. Pigment Cell Melanoma Res., 2019, 32(2), 303-314.
[http://dx.doi.org/10.1111/pcmr.12751] [PMID: 30457212]

Ji, L.; Chen, S.; Gu, L.; Wang, J.; Zhang, X. LncRNA AGAP2-AS1 Promotes Cancer Cell Proliferation, Migration and Invasion in Colon Cancer by Forming a Negative Feedback Loop with LINC-PINT. Cancer Manag. Res., 2021, 13, 2153-2161.
[http://dx.doi.org/10.2147/CMAR.S260371] [PMID: 33688258]

Wu, H.F.; Lu, T-J.; Lo, Y-H.; Tu, Y-T.; Chen, Y-R.; Lee, M-C.; Chiang, Y-L.; Yeh, C-Y.; Tsai, K-W. Long Noncoding RNA LOC550643 Acts as an Oncogene in the Growth Regulation of Colorectal Cancer Cells. Cells, 2022, 11(7), 1065.
[http://dx.doi.org/10.3390/cells11071065] [PMID: 35406629]

Ma, Z.; Huang, H.; Xu, Y.; He, X.; Wang, J.; Hui, B.; Ji, H.; Zhou, J.; Wang, K. Current advances of long non-coding RNA highly upregulated in liver cancer in human tumors. OncoTargets Ther., 2017, 10, 4711-4717.
[http://dx.doi.org/10.2147/OTT.S136915] [PMID: 29026319]

Bida, O.; Gidoni, M.; Ideses, D.; Efroni, S.; Ginsberg, D. A novel mitosis-associated lncRNA, MA-linc1, is required for cell cycle progression and sensitizes cancer cells to Paclitaxel. Oncotarget, 2015, 6(29), 27880-27890.
[http://dx.doi.org/10.18632/oncotarget.4944] [PMID: 26337085]

Zheng, C.; Chu, M.; Chen, Q.; Chen, C.; Wang, Z-W.; Chen, X. The role of lncRNA OIP5-AS1 in cancer development and progression. Apoptosis, 2022.
[http://dx.doi.org/10.1007/s10495-022-01722-3] [PMID: 35316453]

Xu, R.; Peng, H.; Yang, N.; Liu, Z.; Lu, W. Nuclear LncRNA CERNA1 enhances the cisplatin-induced cell apoptosis and overcomes chemoresistance via epigenetic activation of BCL2L10 in ovarian cancer. Genes Dis., 2022.
[http://dx.doi.org/10.1016/j.gendis.2021.12.018]